• RBC Capital Reaffirms Their Buy Rating on Pyxis Oncology (PYXS) The Globe and Mail Fri, 10 Jul 2026 01:54:45 GMT
• Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS) and Nektar Therapeutics (NKTR) The Globe and Mail Tue, 07 Jul 2026 07:14:00 GMT
• Pyxis Oncology Inc (NASDAQ: PYXS) Share Price, PYXS Stock News, PYXS Share Price & Updates Kalkine Tue, 07 Jul 2026 04:24:54 GMT
• H.C. Wainwright reiterates Pyxis Oncology stock rating at buy By Investing.com Investing.com Nigeria Mon, 06 Jul 2026 12:14:15 GMT
• H.C. Wainwright Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Maintains Target Price $7 Moomoo Mon, 06 Jul 2026 10:56:31 GMT
• pyxis oncology outlines its pipeline strategy as it advances antibody-drug conjugate research AD HOC NEWS Fri, 03 Jul 2026 20:38:02 GMT
• Pyxis Oncology Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift Stock - Capex Guidance dars.gov.et Fri, 03 Jul 2026 15:37:44 GMT
• stifel maintains pyxis oncology(pyxs.us) with buy rating, maintains target price $8 Moomoo Fri, 03 Jul 2026 05:40:05 GMT
• PYXS Maintains by Leerink Partners -- Price Target Lowered to $7 GuruFocus Fri, 03 Jul 2026 01:41:15 GMT
• pyxis oncology raises capital through private placement financing TipRanks Thu, 02 Jul 2026 20:54:05 GMT
• Pyxis Oncology (PYXS) director sells 35K shares after option exercise Stock Titan Thu, 02 Jul 2026 20:32:48 GMT
• Pyxis Oncology Raises $50 Million in Private Placement; Warrants Could Add ~$64 Million TradingView Thu, 02 Jul 2026 20:23:01 GMT
• Pyxis Oncology (NASDAQ: PYXS) raises up to $114M in private placement to fund MICVO trials Stock Titan Thu, 02 Jul 2026 20:21:40 GMT
• Leerink cuts Pyxis Oncology stock price target on valuation Investing.com Thu, 02 Jul 2026 10:21:42 GMT
• pyxis oncology, inc. financial disclosures & sec filings TradingView Thu, 02 Jul 2026 01:05:16 GMT
• Pyxis Oncology, Inc. Stock 12‑Month Price Target Raised to $7.14, Implies 137% Upside TradingView Wed, 01 Jul 2026 14:20:06 GMT
• latham & watkins advises on pyxis oncology’s up to us$114 million private placement financing Legal Desire Media and Insights Wed, 01 Jul 2026 08:31:27 GMT
• Guggenheim Sticks to Its Buy Rating for Pyxis Oncology (PYXS) The Globe and Mail Wed, 01 Jul 2026 07:00:00 GMT
• Latham Advises on Pyxis Oncology Up to Private Placement Financing Latham & Watkins LLP Wed, 01 Jul 2026 03:38:52 GMT
• William Blair Maintains Pyxis Oncology(PYXS.US) With Hold Rating 富途牛牛 Tue, 30 Jun 2026 20:32:00 GMT
• Form 144 Pyxis Oncology For: 30 June By Investing.com Investing.com Australia Tue, 30 Jun 2026 20:28:05 GMT
• pyxis oncology, inc. (pyxs) announced the completion of a private financing agreement with a total funding amount up to 114 millio... Bitget Tue, 30 Jun 2026 20:07:41 GMT
• Pyxis Oncology Secures Up to $114 Million Private Placement marketscreener.com Tue, 30 Jun 2026 14:31:21 GMT
• pyxis oncology secures up to $114 million financing to advance micvo clinical program citybiz Tue, 30 Jun 2026 13:25:38 GMT
• pyxis oncology (pyxs) secures $50 million in private placement f GuruFocus Tue, 30 Jun 2026 13:25:25 GMT
• Pyxis Oncology raises up to $114M to fund MICVO trial updates Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Pyxis Oncology raises $50 million in private placement Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• Pyxis Oncology, Inc.(NasdaqGS:PYXS) dropped from Russell Microcap Value Benchmark Index marketscreener.com Mon, 29 Jun 2026 16:32:12 GMT
• Pyxis Oncology, Inc.(NasdaqGS:PYXS) added to Russell Microcap Growth Benchmark Index marketscreener.com Mon, 29 Jun 2026 12:29:05 GMT
• pyxis oncology, inc.(nasdaqgs: pyxs) added to russell 3000e growth benchmark marketscreener.com Mon, 29 Jun 2026 08:47:12 GMT
• pyxis oncology inc (pyxs) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• pyxis oncology inc (pyxs) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 06:18:09 GMT
• pyxis oncology inc (pyxs) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• Pyxis Oncology (PYXS) Q1 2026 Earnings: Small EPS Beat Drives 6.8% Stock Gain Amid No Revenue - Consensus Forecast Report dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• pyxis oncology inc (pyxs) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 12:40:56 GMT
• pyxis oncology inc (pyxs) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 08:55:54 GMT
• pyxis oncology inc (pyxs) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 08:54:09 GMT
• pyxis oncology inc (pyxs) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 08:53:04 GMT
• pyxis oncology inc (pyxs) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 08:30:20 GMT
• Pyxis Oncology Stock - Thursday technicals around key trading levels AD HOC NEWS Thu, 18 Jun 2026 07:00:00 GMT
• Pyxis Oncology (PYXS) Surges 6.8% as Momentum Builds Near Key Resistance - Max Pain Level dars.gov.et Thu, 18 Jun 2026 07:00:00 GMT
• pyxis oncology inc (pyxs) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 20:31:32 GMT
• pyxis oncology inc (pyxs) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 20:29:03 GMT
• pyxis oncology inc (pyxs) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 20:20:42 GMT
• pyxis oncology inc (pyxs) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• pyxis oncology, inc. files form 8-k with sec detailing corporate information and emerging growth status Minichart Tue, 16 Jun 2026 07:00:00 GMT
• pyxis oncology elects directors and ratifies auditor at annual meeting Investing.com Tue, 16 Jun 2026 04:08:59 GMT
• Pyxis Oncology (PYXS) shareholders elect Class II directors and ratify Ernst & Young as 2026 auditor Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Pyxis Oncology elects directors and ratifies auditor at annual meeting Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• pyxis oncology stockholders approve directors and auditor slate TipRanks Mon, 15 Jun 2026 07:00:00 GMT
• pyxis oncology inc. (pyxs) q1 2026 earnings: narrower loss beats estimates as stock rises on clinical progress - free cash flow tr... newsline.com Fri, 12 Jun 2026 21:40:00 GMT
• analysts highlight significant upside potential for pyxis oncology (pyxs) - guidance revision trend newsline.com Fri, 12 Jun 2026 06:20:31 GMT
• Narrower-Than-Expected Loss as Pre-Revenue Oncology Biotech Advances Pipeline - Annual Report dars.gov.et Thu, 11 Jun 2026 07:00:00 GMT
• pyxs q1 2026 earnings: narrower-than-expected loss supports stock uptick - earnings quality analysis newsline.com Wed, 10 Jun 2026 15:47:32 GMT
• Analysts See Nearly 3X Upside in Pyxis Oncology (PYXS) Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
• number of shareholders of pyxis oncology, inc. – nasdaq:pyxs TradingView Tue, 09 Jun 2026 11:00:56 GMT
• pyxis oncology stock draws attention again after jefferies as traders eye micvo results Bez Kabli Fri, 05 Jun 2026 07:00:00 GMT
• pyxis oncology stock (us70611b1026): steady nasdaq trading ahead of valuation focus Ad-hoc-news.de Fri, 05 Jun 2026 07:00:00 GMT
• pyxs stock price, quote & chart | pyxis oncology inc (nasdaq:pyxs) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• hc wainwright & co. maintains pyxis oncology (pyxs) buy recommendation MSN Thu, 04 Jun 2026 14:40:41 GMT
• pyxs: mid-year data will highlight micvo's efficacy and safety in head and neck cancer, supporting pivotal plans TradingView Thu, 04 Jun 2026 12:24:48 GMT
• pyxs: mid-year data will clarify micvo's efficacy, safety, and pivotal trial path in head and neck cancer TradingView Thu, 04 Jun 2026 07:00:00 GMT
• pyxis oncology inc. (pyxs) q1 2026 earnings: narrower-than-expected loss as clinical pipeline advances - financial data newsline.com Thu, 04 Jun 2026 07:00:00 GMT
• pyxis oncology (pyxs) holds steady at $1.80 as biotech sector watches key levels - daily profile newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• pyxis oncology (pyxs) q1 2026 earnings: narrower-than-expected loss amid no revenue - earnings growth analysis newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• Pyxis Oncology Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Sentiment - Quarterly Earnings dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• pyxis oncology edges higher as shares test key resistance levels - kama signal newsline.com Thu, 28 May 2026 07:00:00 GMT
• lifesci capital maintains pyxis oncology(pyxs.us) with buy rating, maintains target price $6 Moomoo Sat, 23 May 2026 07:00:00 GMT
• pyxs q1 2026 earnings: better-than-expected loss highlights progress in oncology pipeline - revenue report The Legal Advocate Sat, 23 May 2026 07:00:00 GMT
• pyxis oncology q1 2026 earnings: narrower-than-expected loss drives positive market reaction - profit recovery report newsline.com Sat, 23 May 2026 04:30:06 GMT
• pyxis oncology q1 2026 earnings: narrower-than-expected loss drives positive market reaction - earnings surprise report The Legal Advocate Fri, 22 May 2026 07:00:00 GMT
• wedbush maintains pyxis oncology(pyxs.us) with buy rating, maintains target price $6 富途牛牛 Thu, 21 May 2026 13:13:59 GMT
• PYXS: MICVO demonstrates high efficacy and improved safety in head and neck cancer with dose capping TradingView Tue, 19 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: pyxis oncology (pyxs) and actuate therapeutics, inc. (actu) The Globe and Mail Tue, 19 May 2026 07:00:00 GMT
• pyxis oncology (pyxs) rating reiterated as buy by hc wainwright & co. | pyxs stock news GuruFocus Mon, 18 May 2026 10:54:21 GMT
• Wedbush Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Maintains Target Price $6 Moomoo Mon, 18 May 2026 07:00:00 GMT
• lifesci capital maintains pyxis oncology(pyxs.us) with buy rating, raises target price to $6 Moomoo Mon, 18 May 2026 07:00:00 GMT
• pyxis oncology stock (us70611b1026): new clinical update keeps focus on its cancer pipeline AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• pyxis oncology (pyxs) stock: jumps +3.17%, approaching $2.39 2026-05-17 - chaikin flow newsline.com Sun, 17 May 2026 07:00:00 GMT
• Pyxis Oncology (PYXS) Cash Runway Under One Year Reinforces Bearish Funding Narratives simplywall.st Sat, 16 May 2026 07:00:00 GMT
• rbc capital keeps their buy rating on pyxis oncology (pyxs) The Globe and Mail Sat, 16 May 2026 07:00:00 GMT
• wedbush maintains pyxis oncology(pyxs.us) with buy rating, maintains target price $6 Moomoo Sat, 16 May 2026 04:31:00 GMT
• a quick look at today's ratings for pyxis oncology(pyxs.us), with a forecast between $5 to $7 Moomoo Fri, 15 May 2026 23:34:44 GMT
• pyxis oncology, inc. faces substantial doubt as a going concern and requires additional capital – 2026 q1 financial report highlig... Minichart Fri, 15 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: pyxis oncology (pyxs) and journey medical corp (derm) The Globe and Mail Fri, 15 May 2026 07:00:00 GMT
• pyxis oncology reports q1 2026 financial results and advances micvo adc toward key clinical milestones in head and neck cancer Minichart Fri, 15 May 2026 07:00:00 GMT
• pyxis oncology faces urgent capital needs and potential dilution risks amid market volatility TipRanks Fri, 15 May 2026 06:15:32 GMT
• pyxis oncology, inc. faces substantial doubt as a going concern and requires additional capital – 2026 q1 financial report highlig... Minichart Thu, 14 May 2026 19:47:00 GMT
• pyxis oncology reports q1 2026 financial results and advances micvo adc toward key clinical milestones in head and neck cancer Minichart Thu, 14 May 2026 16:18:00 GMT
• press release: pyxis oncology reports first quarter 2026 financial results and advances micvo toward key 2026 clinical milestones Moomoo Thu, 14 May 2026 11:00:00 GMT
• Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• pyxis oncology (pyxs) posts $23.3m q1 loss and advances micvo trials Stock Titan Thu, 14 May 2026 07:00:00 GMT
• pyxis oncology (pyxs) q1 2026 loss deepens as micvo trials expand and cash runway tightens Stock Titan Thu, 14 May 2026 07:00:00 GMT
• cancer-drug maker pyxis lines up key 2026 micvo trial readouts Stock Titan Thu, 14 May 2026 07:00:00 GMT
• pyxis oncology stock (us70611b1026): q1 2026 loss widens to $23.3m AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• pyxis oncology faces urgent capital needs and potential dilution risks amid market volatility TipRanks Thu, 14 May 2026 07:00:00 GMT
• should you sell pyxis oncology (pyxs) after -18.89% drop? 2026-05-14 - bullish percent index newsline.com Thu, 14 May 2026 07:00:00 GMT
• pyxis oncology inc reports results for the quarter ended march 31 - earnings summary TradingView Thu, 14 May 2026 07:00:00 GMT
• pyxis oncology, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 14 May 2026 07:00:00 GMT
• Pyxis Oncology to Participate in Upcoming Investor Conferences The Manila Times Wed, 13 May 2026 07:00:00 GMT
• cancer drug developer pyxis oncology plans investor webcasts Stock Titan Wed, 13 May 2026 07:00:00 GMT
• pyxs stock price, quote & chart | pyxis oncology inc (nasdaq:pyxs) ChartMill Wed, 13 May 2026 07:00:00 GMT
• pyxis oncology (pyxs) upgraded to strong buy: here's what you should know MSN Wed, 13 May 2026 00:39:09 GMT
• pyxis oncology (pyxs) upgraded to strong buy: here's what you should know MSN Tue, 12 May 2026 23:40:20 GMT
• pyxis oncology stock (us70611b1026): builds $540m cash pile after q1 loss Ad-hoc-news.de Tue, 12 May 2026 07:00:00 GMT
• creative global technology holdings and 2 other promising penny stocks simplywall.st Tue, 12 May 2026 07:00:00 GMT
• pyxis oncology inc expected to post a loss of 37 cents a share - earnings preview TradingView Mon, 11 May 2026 07:00:00 GMT
• pyxis oncology appoints nelson azoulay as chief business officer The Manila Times Fri, 08 May 2026 07:00:00 GMT
• Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer GlobeNewswire Thu, 07 May 2026 07:00:00 GMT
• Pyxis brings in former ImmunoGen dealmaker to advance MICVO Stock Titan Thu, 07 May 2026 07:00:00 GMT
• pyxis oncology, inc. appoints nelson azoulay as chief business officer marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• pyxis oncology, inc. (nasdaq:pyxs) given average recommendation of "moderate buy" by brokerages MarketBeat Thu, 07 May 2026 07:00:00 GMT
• the nasdaq biotechnology index closed up more than 2.1%. among its constituents, pyxis oncology rose 25.68%, veracyte gained 25.08... Bitget Wed, 06 May 2026 07:00:02 GMT
• wedbush rates pyxs; reaffirms tvtx, oric, nuvb at outperform; lifts price target for tvtx RTTNews Wed, 06 May 2026 07:00:00 GMT
• wedbush bullish on pyxis oncology, initiates with an outperform TipRanks Tue, 05 May 2026 16:30:35 GMT
• wedbush initiates pyxis oncology(pyxs.us) with buy rating, announces target price $6 Moomoo Tue, 05 May 2026 11:34:00 GMT
• Wedbush Initiates Pyxis Oncology at Outperform With $6 Price Target marketscreener.com Tue, 05 May 2026 07:00:00 GMT
• wedbush initiates coverage of pyxis oncology (pyxs) with outperform recommendation MSN Tue, 05 May 2026 07:00:00 GMT
Pyxis Oncology, Inc.(NASDAQ:PYXS) 
Pyxis Oncology, Inc., a preclinical stage biotechnology company, engages in the development of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies to treat cancers. Its preclinical products pipeline includes PYX-201, a site-specific investigational ADC targeting onco-fetal ...
Share this website to your friends